← All trials
NCT00432562
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2007
- Primary completion
- Nov 1, 2007
- Completion date
- Dec 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 31
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Mast TherapeuticsLead sponsor
- Fundación Centro Oncológico de Integración Regional - COIR.Overall official - principal investigator
- Hospital Privado De Santa Clara De AsisOverall official - principal investigator
- Hospital Regional De ConcepciónOverall official - principal investigator
- CIMA SaludOverall official - principal investigator
- Synteract, Inc.Collaborator
- Thywill Latam Solutions SRLCollaborator
- Worldwide Clinical TrialsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.